RUNX transcription factors as key targets of TGF-β superfamily signaling
- 14 January 2003
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Genetics & Development
- Vol. 13 (1), 43-47
- https://doi.org/10.1016/s0959-437x(03)00007-8
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Disruption of Smad5 gene leads to enhanced proliferation of high-proliferative potential precursors during embryonic hematopoiesisBlood, 2003
- Differential Requirements for Runx Proteins in CD4 Repression and Epigenetic Silencing during T Lymphocyte DevelopmentCell, 2002
- Divergence and convergence of TGF‐β/BMP signalingJournal of Cellular Physiology, 2001
- Three chromosomal rearrangements in neuroblastoma cluster within a 300‐kb region on 1p36.1Genes, Chromosomes and Cancer, 2001
- Runx2 Is a Common Target of Transforming Growth Factor β1 and Bone Morphogenetic Protein 2, and Cooperation between Runx2 and Smad5 Induces Osteoblast-Specific Gene Expression in the Pluripotent Mesenchymal Precursor Cell Line C2C12Molecular and Cellular Biology, 2000
- TGFβ Signaling in Growth Control, Cancer, and Heritable DisordersCell, 2000
- Smad and AML Proteins Synergistically Confer Transforming Growth Factor β1 Responsiveness to Human Germ-line IgA GenesPublished by Elsevier BV ,2000
- Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasiaNature Genetics, 1997
- AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver HematopoiesisCell, 1996
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992